Find clinical trials for Endometrial Cancer in Birmingham, AL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Cancer

Carcinoma

Ovarian Cancer

Breast Cancer

Triple Negative Breast Cancer

Ovarian Epithelial Carcinoma

Colorectal Cancer

Endometrial Cancer trials near Birmingham, AL, USA:

Phase II Study of Atezolizumab + Bevacizumab in Endometrial Cancer

This is a single arm, Phase II study using the combination of atezolizumab and bevicacizumab in women with advanced, recurrent or persistent endometrial...

Active, not recruiting

Endometrial Cancer

Drug: Atezolizumab

Drug: Bevacizumab

Phase 2

University of Oklahoma (OU)

Birmingham, Alabama, United States and 2 other locations

Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)

The purpose of this study is to compare pembrolizumab + adjuvant chemotherapy with placebo + adjuvant chemotherapy, with or without radiotherapy, wit...

Active, not recruiting

Endometrial Neoplasms

Drug: Placebo for pembrolizumab

Drug: Cisplatin

Phase 3

Merck Sharp & Dohme (MSD)

Birmingham, Alabama, United States and 230 other locations

NM32-2668 in Adult Patients with Selected Advanced Solid Tumors

tumors....

Enrolling

Endometrial Cancer

Triple Negative Breast Cancer

Biological: NM32-2668

Phase 1

Numab Therapeutics

Birmingham, Alabama, United States and 7 other locations

Study of REGN4018 Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers

can be given alone or with cemiplimab to patients with ovarian cancer or cancer of the uterus* The study will also look at the leve...

Enrolling

Recurrent Primary Peritoneal Cancer

Recurrent Ovarian Cancer

Drug: REGN4018

Drug: Sarilumab

Phase 1, Phase 2

Regeneron Pharmaceuticals

Birmingham, Alabama, United States and 49 other locations

Selinexor in Maintenance Therapy After Systemic Therapy for Participants with P53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma (XPORT-EC-042)

The purpose of this study is to evaluate the efficacy and safety of selinexor as a maintenance treatment in patients with p53 wt endometrial...

Enrolling

Endometrial Cancer

Drug: Matching Placebo for selinexor

Drug: Selinexor

Phase 3

Karyopharm Therapeutics

Birmingham, Alabama, United States and 165 other locations

Study of XB002 in Subjects With Solid Tumors (JEWEL-101)

and clinical antitumor activity of XB002 administered IV q3w alone and in combination with nivolumab to subjects with advanced solid tumors....

Active, not recruiting

Endometrial Cancer

Tissue Factor-Expressing Solid Tumors

Drug: XB002

Drug: Nivolumab

Phase 1

Exelixis

Birmingham, Alabama, United States and 94 other locations

A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors

to participants with locally advanced or metastatic solid tumors with certain KRAS mutations. LY4066434 will be given alone or in combinatio...

Enrolling

Advanced Solid Tumor

Non-small Cell Lung Cancer

Drug: Pembrolizumab

Drug: Irinotecan

Phase 1

Lilly

Birmingham, Alabama, United States and 23 other locations

Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)

The purpose of this study is to find out whether the study drug, LY3537982, is safe and effective in cancer patients who have a specific gen...

Enrolling

Ovarian Neoplasms

Biliary Tract Neoplasms

Drug: Cetuximab

Drug: Cisplatin

Phase 1, Phase 2

Lilly

Birmingham, Alabama, United States and 49 other locations

Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid Tumors (GARNET)

(also known as TSR-042) n participants with advanced solid tumors who have limited available treatment options. The study will be conducted ...

Enrolling

Neoplasms

Biological: Dostarlimab

Phase 1

Tesaro

Birmingham, Alabama, United States and 144 other locations

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms

Find clinical trials for Endometrial Cancer in .css-epvm6{white-space:nowrap;}Birmingham, AL

Related conditions:

Endometrial Cancer trials near Birmingham, AL, USA:

Phase II Study of Atezolizumab + Bevacizumab in Endometrial Cancer

Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)

NM32-2668 in Adult Patients with Selected Advanced Solid Tumors

Study of REGN4018 Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers

Selinexor in Maintenance Therapy After Systemic Therapy for Participants with P53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma (XPORT-EC-042)

Study of XB002 in Subjects With Solid Tumors (JEWEL-101)

A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors

Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)

Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid Tumors (GARNET)

Find clinical trials for Endometrial Cancer in Birmingham, AL